13-Feb-2026
Top Exponent Executive Makes Bold Move With Major Stock Sell-Off
TipRanks (Thu, 12-Feb 9:05 PM ET)
Exponent Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Globe Newswire (Thu, 5-Feb 4:05 PM ET)
Exponent Increases Quarterly Dividend Payment from $0.30 to $0.31 per Share for Q1 2026
Globe Newswire (Thu, 5-Feb 4:05 PM ET)
Globe Newswire (Thu, 15-Jan 4:05 PM ET)
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Exponent trades on the NASDAQ stock market under the symbol EXPO.
As of February 13, 2026, EXPO stock price declined to $66.79 with 920,477 million shares trading.
EXPO has a beta of 0.73, meaning it tends to be less sensitive to market movements. EXPO has a correlation of 0.18 to the broad based SPY ETF.
EXPO has a market cap of $3.33 billion. This is considered a Mid Cap stock.
Last quarter Exponent reported $147 million in Revenue and $.49 earnings per share. This beat revenue expectation by $17 million and exceeded earnings estimates by $.02.
In the last 3 years, EXPO traded as high as $115.75 and as low as $63.81.
The top ETF exchange traded funds that EXPO belongs to (by Net Assets): VTI, IJH, IWM, VB, SDVY.
EXPO has underperformed the market in the last year with a price return of -24.9% while the SPY ETF gained +13.0%. EXPO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -4.1% and -7.1%, respectively, while the SPY returned +1.7% and -1.5%, respectively.
EXPO support price is $65.41 and resistance is $68.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EXPO shares will trade within this expected range on the day.